Three pairs of TGF-β-treated isogenic NSCLC cell lines (H1975, HCC4006, and HCC366) and two mesenchymal NSCLC cell lines (Calu6 and H1792) were incubated with 50nM volasertib for 24 hours, lysed, and subjected to reverse phase protein array analysis. Experiments were done in triplicate. 